You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 2, 25 JAN 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

National High Blood Pressure Education Program Working Group Report on Primary Prevention of Hypertension

Arch Intern Med. 1993;153(2):186-208.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THE United States and most other societies, blood pressure and the prevalence of high blood pressure rise progressively with increasing age. High blood pressure is among the most common and most important of the risk factors for cardiovascular-renal disease. To date, blood pressure— related risk reduction efforts have almost uniformly revolved around the paradigm of hypertension detection and treatment. Despite the clear benefits of treating established hypertension, this approach alone will not prevent all of the blood pressure— related cardiovascular-renal disease in the community. Blood pressure—related vascular complications can occur before the onset of established hypertension because the blood pressure—cardiovascular disease risk relationship is continuous and progressive, even within the normotensive blood pressure range. Furthermore, it is difficult to ensure that all hypertensive persons are detected and treated adequately. In addition, many hypertensive treatment regimens are expensive, especially those including new drugs, and almost all carry the potential for . . . [Full Text PDF of this Article]


Footnotes

From the National High Blood Pressure Education Program Working Group.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.